ArticleJournal of thoracic disease2026
Conventional chest CT features are associated with Ki-67 labeling index in lung adenocarcinoma: a single-center retrospective radiopathologic study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ki-67 labeling index (LI) reflects tumor proliferative activity but requires pathological specimens and may be affected by sampling heterogeneity. This study evaluated associations between conventional chest computed tomography (CT) features and Ki-67 LI in lung adenocarcinoma. Methods: This single-center retrospective study included patients with pathologically confirmed primary lung adenocarcinoma who underwent pretreatment chest CT and Ki-67 immunohistochemistry between January 2021 and January 2025. Ki-67 LI ≥20% was used as the primary threshold for analysis. Clinicopathological characteristics and CT features were compared between the Ki-67 LI <20% and Ki-67 LI ≥20% groups. Univariable and multivariable logistic regression analyses were performed, adjusting for age, sex, smoking status, clinical stage, tumor differentiation, and specimen type. Sensitivity analyses used a 30% Ki-67 threshold and a surgical-specimen subgroup. Results: Among 252 included patients, 125 had low Ki-67 LI and 127 had Ki-67 LI ≥20%. Ki-67 LI ≥20% was associated with aggressive clinicopathological features, including unfavorable growth pattern, poor differentiation, advanced stage, N-positive disease, visceral pleural invasion, and lymphovascular invasion. On CT, Ki-67 LI ≥20% tumors had larger maximum diameter, higher consolidation-to-tumor ratio, more frequent solid appearance, and more pleural indentation. In multivariable analysis, pleural indentation was the only CT feature that retained a significant adjusted association with Ki-67 LI ≥20% (adjusted odds ratio, 2.07; 95% confidence interval, 1.15-3.73; P=0.02). This association persisted in the surgical-specimen subgroup but was not reproduced when Ki-67 LI ≥30% was used as the alternative threshold. Conclusions: In lung adenocarcinoma, pleural indentation was the most stable conventional CT feature independently associated with Ki-67 LI ≥20%. Conventional CT may provide accessible clues to tumor proliferation but should complement pathological Ki-67 assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.